Advertisement

Topics

Helsinn Group presents phase III data in NEPA at MASCC/ISOO Congress

10:30 EDT 21 Jun 2017 | CentreWatch

Helsinn, a Swiss pharmaceutical group focused on building quality cancer care products, has announced that data showing the non-inferiority of NEPA (netupitant/palonestron) versus a 3-day oral aprepitant (APR)/granisetron (GRAN) regimen, have been accepted for presentation at the upcoming Multinational Association of Supportive Care in Cancer (MASCC/ISOO) Congress, on June 22-24 2017. NEPA is the first […]

The post Helsinn Group presents phase III data in NEPA at MASCC/ISOO Congress appeared first on CenterWatch News Online.

Original Article: Helsinn Group presents phase III data in NEPA at MASCC/ISOO Congress

NEXT ARTICLE

More From BioPortfolio on "Helsinn Group presents phase III data in NEPA at MASCC/ISOO Congress"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Cancer
  Bladder Cancer Brain Cancer Breast Cancer Cancer Cervical Cancer Colorectal Head & Neck Cancers Hodgkin Lymphoma Leukemia Lung Cancer Melanoma Myeloma Ovarian Cancer Pancreatic Cancer ...

Cancer Disease
Cancer is not just one disease but many diseases. There are more than 100 different types of cancer. Most cancers are named for the organ or type of cell in which they start - for example, cancer that begins in the colon is called colon cancer; cancer th...